Mirum Pharmaceuticals, Inc.
MIRM
57 insider filings · Latest: Oct 9, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 17 10:58 PM | Peter Radovich | Proposed Sale | 16,515 | $92.64 | $1.5M | — | View → |
| Mar 16, 2026 | Mar 17 10:55 PM | Jolanda Howe | Proposed Sale | 4,732 | $92.64 | $438.4K | — | View → |
| Mar 16, 2026 | Mar 17 10:50 PM | Christopher Peetz | Proposed Sale | 40,985 | $92.64 | $3.8M | — | View → |
| Mar 16, 2026 | Mar 16 8:04 PM | SAIRA RAMASASTRY | Proposed Sale | 2,000 | $90.76 | $181.5K | — | View → |
| Feb 13, 2026 | Feb 17 9:38 PM | Saira RamasastryDirector | Sale | 2,000 | $102.09 | $204.2K | 0(D) | View → |
| Feb 13, 2026 | Feb 13 9:04 PM | SAIRA RAMASASTRY | Proposed Sale | 2,000 | $102.09 | $204.2K | — | View → |
| Feb 2, 2026 | Feb 4 2:45 AM | Peter RadovichPRESIDENT AND COO | Sale | 2,631 | $103.30 | $271.8K | 20,655(D) | View → |
| Feb 2, 2026 | Feb 4 2:45 AM | Christopher PeetzDirector, CHIEF EXECUTIVE OFFICER | Sale | 9,108 | $103.30 | $940.9K | 160,294(D) | View → |
| Feb 2, 2026 | Feb 4 2:45 AM | Jolanda HoweSVP, GLOBAL CONTROLLER | Sale | 968 | $103.30 | $100.0K | 4,503(D) | View → |
| Feb 2, 2026 | Feb 3 1:29 AM | Jolanda Howe | Proposed Sale | 968 | $103.80 | $100.5K | — | View → |
| Feb 2, 2026 | Feb 3 1:25 AM | Peter Radovich | Proposed Sale | 2,631 | $103.80 | $273.1K | — | View → |
| Feb 2, 2026 | Feb 3 1:21 AM | Christopher Peetz | Proposed Sale | 9,108 | $103.80 | $945.4K | — | View → |
| Jan 26, 2026 | Jan 28 11:47 PM | Jolanda Howe | Proposed Sale | 842 | $96.92 | $81.6K | — | View → |
| Jan 26, 2026 | Jan 28 11:44 PM | ERIC BJERKHOLT | Proposed Sale | 1,053 | $96.92 | $102.1K | — | View → |
| Jan 26, 2026 | Jan 28 11:43 PM | Peter Radovich | Proposed Sale | 3,143 | $96.92 | $304.6K | — | View → |
| Jan 26, 2026 | Jan 28 11:40 PM | Christopher Peetz | Proposed Sale | 6,831 | $96.92 | $662.1K | — | View → |
| Jan 26, 2026 | Jan 27 9:30 PM | Eric BjerkholtCHIEF FINANCIAL OFFICER | Sale | 1,053 | $96.19 | $101.3K | 43,741(D) | View → |
| Jan 26, 2026 | Jan 27 9:30 PM | Peter RadovichPRESIDENT AND COO | Sale | 3,143 | $96.19 | $302.3K | 23,286(D) | View → |
| Jan 26, 2026 | Jan 27 9:30 PM | Jolanda HoweSVP, GLOBAL CONTROLLER | Sale | 842 | $96.19 | $81.0K | 3,700(D) | View → |
| Jan 26, 2026 | Jan 27 9:30 PM | Christopher PeetzDirector, CHIEF EXECUTIVE OFFICER | Sale | 6,831 | $96.19 | $657.1K | 169,402(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Jun 2 11:50 PM | Saira RamasastryDirector | Option Exercise | 3,977 | — | 0(D) | View → |
| May 29, 2026 | Jun 2 11:50 PM | Laurent FischerDirector | Option Exercise | 3,977 | — | 0(D) | View → |
| May 15, 2026 | May 19 12:32 AM | Saira RamasastryDirector | Option Exercise | 2,000 | $23.51 | 0(D) | View → |
| Apr 15, 2026 | Apr 17 12:40 AM | Saira RamasastryDirector | Option Exercise | 2,000 | $23.51 | 2,000(D) | View → |
| Mar 15, 2026 | Mar 17 11:30 PM | Eric BjerkholtCHIEF FINANCIAL OFFICER | Option Exercise | 13,334 | — | 6,666(D) | View → |
| Mar 15, 2026 | Mar 17 11:30 PM | Joanne QuanCHIEF MEDICAL OFFICER | Option Exercise | 13,334 | — | 6,666(D) | View → |
| Mar 16, 2026 | Mar 17 11:30 PM | Saira RamasastryDirector | Option Exercise | 2,000 | $23.51 | 4,000(D) | View → |
| Mar 15, 2026 | Mar 17 11:30 PM | Peter RadovichPRESIDENT AND COO | Option Exercise | 30,220 | — | 11,500(D) | View → |
| Mar 15, 2026 | Mar 17 11:30 PM | Jolanda HoweSVP, GLOBAL CONTROLLER | Option Exercise | 8,658 | — | 3,000(D) | View → |
| Mar 15, 2026 | Mar 17 11:30 PM | Christopher PeetzDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 75,000 | — | 25,000(D) | View → |
| Mar 6, 2026 | Mar 11 8:05 PM | Peter RadovichPRESIDENT AND COO | Option Exercise | 5,912 | $15.87 | 54,088(D) | View → |
| Feb 13, 2026 | Feb 17 9:38 PM | Saira RamasastryDirector | Option Exercise | 2,000 | $23.51 | 6,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:45 AM | Jolanda HoweSVP, GLOBAL CONTROLLER | Option Exercise | 1,771 | — | 0(D) | View → |
| Jan 28, 2026 | Jan 30 11:30 PM | Jolanda HoweSVP, GLOBAL CONTROLLER | Grant/Award | 21,650 | $100.85 | 9,000(D) | View → |
| Jan 28, 2026 | Jan 30 11:30 PM | Joanne QuanCHIEF MEDICAL OFFICER | Grant/Award | 49,900 | $100.85 | 20,000(D) | View → |
| Jan 28, 2026 | Jan 30 11:30 PM | Eric BjerkholtCHIEF FINANCIAL OFFICER | Grant/Award | 49,900 | $100.85 | 20,000(D) | View → |
| Jan 28, 2026 | Jan 30 11:30 PM | Peter RadovichPRESIDENT AND COO | Grant/Award | 75,900 | $100.85 | 34,500(D) | View → |
| Jan 28, 2026 | Jan 30 11:30 PM | Christopher PeetzDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 185,500 | $100.85 | 75,000(D) | View → |
| Jan 23, 2026 | Jan 27 9:30 PM | Eric BjerkholtCHIEF FINANCIAL OFFICER | Option Exercise | 2,667 | — | 2,666(D) | View → |
| Jan 23, 2026 | Jan 27 9:30 PM | Peter RadovichPRESIDENT AND COO | Option Exercise | 5,750 | — | 5,750(D) | View → |